2025-10-20
Highlight Capital’s Steven Wang: China’s Biotech Sector Has Entered a “True Innovation Phase”
How the ecosystem has matured from imitation to genuine, IP-driven breakthroughs that are now shaping global healthcare markets.
2025-08-11
HLC Portfolio Company Ab&B Bio-Tech Makes Record-Breaking Debut on Hong Kong Stock Exchange
Ab&B Bio-Tech is a pioneer in next-generation vaccine development
2025-07-29
VelaVigo Announces Over $60 Million in Pre-A+ Financing
to Accelerate Global Clinical Development of First-in-Class Drug Pipeline
2025-07-10
NUCLIDIUM Closes CHF 79 Million (EUR 84 Million) Series B Financing
to advance the clinical development of NUCLIDIUM's Copper-61/Copper-67 (61Cu/67Cu) theranostic pipeline across multiple oncology indications
2025-05-29
HLC Invests in Tawada Healthcare to Support Health System Strengthening in Indonesia
Expand access to affordable, high-quality medical products and accelerate the transfer of essential healthcare technologies across Indonesia
2025-05-07